Fig. 1.
Fig. 1. Validation of the flow cytometry method to quantify blood IPCs. / (A) Total viable PBMCs were gated based on their forward and side scatter (left panel). After a 2-color staining with anti–CD4-PE and (CD3, CD14, CD16, CD20, CD11c)-FITC, IPCs were identified as CD4+FITC− cells (right panel). CD4+ T cells were identified as CD4highFITChigh cells (right panel). For the IPC quantification, 105 PBMCs were analyzed and the percentage of cells was determined by using the quadrant-stat function (CellQuest). For purification of IPCs, CD4+FITC− cells were sorted. (B) Purified IPCs display a typical plasmacytoid morphology on cytospin preparation after Giemsa staining (×100). (C) Purified IPCs produce high amounts of type I IFN after 24 hours' stimulation with herpes simplex virus-1 as compared to cultures in medium alone.

Validation of the flow cytometry method to quantify blood IPCs.

(A) Total viable PBMCs were gated based on their forward and side scatter (left panel). After a 2-color staining with anti–CD4-PE and (CD3, CD14, CD16, CD20, CD11c)-FITC, IPCs were identified as CD4+FITC cells (right panel). CD4+ T cells were identified as CD4highFITChigh cells (right panel). For the IPC quantification, 105 PBMCs were analyzed and the percentage of cells was determined by using the quadrant-stat function (CellQuest). For purification of IPCs, CD4+FITC cells were sorted. (B) Purified IPCs display a typical plasmacytoid morphology on cytospin preparation after Giemsa staining (×100). (C) Purified IPCs produce high amounts of type I IFN after 24 hours' stimulation with herpes simplex virus-1 as compared to cultures in medium alone.

Close Modal

or Create an Account

Close Modal
Close Modal